Ozempic, Wegovy and Mounjaro: Why Ireland is struggling to fund the new weight-loss drugs
One advocate said: 'If you treat obesity, you effectively prevent other cardiorenal metabolic diseases'. Picture: iStock
Weight-loss wonder drugs have had quite a week.
First, they were described as a great source of hope by the WHO (World Health Organization) but, within days, some were labelled as too expensive for the public health system in Ireland.
CONNECT WITH US TODAY
Be the first to know the latest news and updates
